12MP : The M40 will be encouraged to subscribe to health and employment insurance to mitigate them from financial vulnerability. In addition, income tax relief on health and life as well as employment insurance for the M40 will be reviewed to reduce healthcare costs. These initiatives will cushion them from unforeseen circumstances due to health and work-related risks.
The Government financial burden will be reduced gradually in providing sustainable quality healthcare services. The Malaysia National Health Accounts report will be strengthened by incorporating a more detailed analysis of public health expenditure as a tool to identify cost drivers within the health system. Current healthcare charges will be reviewed so that higher income patients will be required to pay higher charges. Subsidies for healthcare services will be streamlined based on a means test.
Efforts will be undertaken to encourage the rakyat to have insurance and takaful in financing healthcare expenses.
I am very positive and keen that share price of Allianz will be skyrocketing very soon due to
1) Positive sentiment in the market (re-opening of economic activities which also means more business activities that will lead to more potential business in insurance as well);
2) Political stability (as PH has promised not to have any election until mid of year 2022);
3) Public awareness of the importance of having health and life insurance during and post pandemic; and
4) High likelihood of favorable Budget 2022 that will be beneficial to Malaysian and business so as to help and speed up recovery of economy
To me, all bad or negative conditions had already passed, which has been evidenced in the Share Price plummeted during the 52 weeks or the year at RM12.48.
Good news will keep coming soon and personally I feel that if you wanted to make money whether on a short, mid or long term, now is a right timing. Share price of Allianz below RM13 is still considered low and cheap comparing to the Intrinsic Value of the Share.
Do not forget also about Window Dressing period which is likely to come in December 2021. I have already placed all 100% of my second pool of funds in Allianz and wait for the price to go up gradually from now to December 2021.
if you are aware of the recent institutional acquisition of Allianz, you will notice that the great "Whale" or EPF has been collecting Allianz without any disposals since mid of year 2021.
What are you waiting for? Collect now before it is too late. A lot of retail investors make losses in stock trading because they only bought the shares when the price had been overvalued or when institutional investors like EPF is getting ready to dump the share or they only bought the shares when the share price had been increased tremendously. Remember, one advice, buy only when not many people are buying. I bought and collected Allianz Shares on dip.
Disclaimer: - Buy or Sell or Hold is your own decision and responsibility. The information above is only for sharing as it is my personal view or opinion; the above information shall not be construed or deemed as an advice for any investment or divestment decision.
I promote Allianz because I do not like those so called Expert in the market. Quietly bought and when the price is high only share or recommend the shares to ppl
I would like to share good stocks and let's earn together.
For long term or value investors, can hold long term no problem. I believe Allianz can be a multibagger.
In term of ESG Compliance, I also believe Allianz has outperformed many blue chips.
For mid or short term traders, I believe as long as your TP is not too high, you can always take profit by selling earlier than EPF and other institutional investors.
Do not forget those Institutional Investors like EPF, they cannot simply sell at lower price because they have a target to meet in order to achieve return desired by its capital providers like EPF members and other stakeholders.
The reason is very simple. This stock is very much Undervalued.
Despite difficult time in year 2020, the result of Allianz Malaysia was still impressive.
1) Operating Revenue -- Increased 7.4% 2) Gross Written premium -- Increased 7.8% 3) Total Assets -- Increased 11.1% 4) Profit Before Tax -- Increased 5.4% 5) Shareholders' Funds -- Increased 9.7% 6) Basic Earnings Per Share -- Increased 11.6%
Intrinsic Value ("IV") which was calculated based on readily available information as of 3 Dec 2020 = RM20.71
The above IV was before the final and audited result for FY2020.
Indeed, EPF has been collecting from time to time.
In my humble opinion the current price of RM12.76 is very much Undervalued. I feel that it is a hidden diamond which a lot of investors might overlook.
BNM publishes a report on Impact of Medical Re-pricing Deferrals on Life Insurers and Family Takaful Operators.
My takeaways after reading:
• Between 2015-19, the combined ratios of Life and Takaful Operators (ITOs) is broadly within 90%-100%. • The combined ratio declined in 2020 as policyholders delay non-critical medical treatment. But the average cost per treatment was up 14%-15%, higher than long term trend of 8%-9%. The higher cost mainly due to pandemic-related protocols may persist in the future. • However, as movement control is lifted, the number of claims is expected to normalize, or may temporarily exceed past level. • Most ITOs agreed to defer re-pricing to preserve affordability. Their margin could be squeezed.
Insurers are under pressure not to reprice given policyholders are still suffering from the economic fallouts. It may impact different ITOs differently. For example, ITOs that rely more on credit products like STMB face a lesser impact than Allianz, who in turn fare better than pure life insurers?
I don’t have the details and am not capable to judge the magnitude. Just throw up a thought for others to comment.
@auditorandconsultant Can you share your source of intrinsic value calculation?
I looked up a few broker reports. They value the GI business based on book value. The multiple ranges from 1.2X to 1.6X. The book value estimate varies greatly from FY19A RM2.1b to FY22F RM3b. However I’m skeptical that book value can grow >40% in 3 years. At least one of them must be very wrong.
For the life business, the embedded value (EV) is estimated to be RM2.6b (as of Jun20) to RM3.3b (as of Jun21). Again the difference is rather big. Most apply a multiplier of 1.0X which makes sense. But not sure how they get the actuarial estimation. But none assign any value to the NBV growth which should bring in value too.
Allianz doesn’t disclose its own EV estimation. I also don’t know how to work out its GI book value based on its quarterly or annual report info. Appreciate if anyone can share their estimation approach.
NB multiplier for well established companies is typically > 10. It can be super high for countries like India and lower in matured market. Even if just assumed 10, and use the YE20 Allianz Life NBV, that is additional 2bil+ on top of current valuation. Some sample number here : https://www.set.or.th/set/pdfnews.do?newsId=15289333958740&sequence=0
Another thing on VIF (part of EV) calculation, since VIF is basically PV of distributable profit, and since Allianz is heavily selling ILP medical, the VIF amount is actually depending on Allianz calculation methodology. In practice, insurers don't typically assume perpetual medical inflation in the VIF calculation, but in reality the medical inflation will be perpetual. What this means is, the absolute amount of future profit, will only be much higher (assume no interference with the medical repricing).
@wsb_investor, Thank you for the important info. Does this NB multiplier correlate mainly with NBV growth rate? If so, do Allianz Ayudhya and Allianz Malaysia have comparable growth rate so that the 10-12 times range is a reasonable choice?
May I ask another question on EV multiple. While 1X seems to make sense, under what circumstance could the EV estimation be grossly wrong?
I notice Chinese life insurers are sold grossly below their EV. Assuming market is rational what could it imply? Major asset write-off? Could such scenario happen here?
EV is based on a lot assumptions. The assumptions can be conservative or aggressive. For example, aggressive will be high earning rate with low discount rate. Allianz adopts MCEV, or in layman term, risk free earning rate + risk free discount rate. EV also relies a lot on methodology, for example lapse rate, repricing, bonus etc. Investors typically have lesser faith in China inhouse methodology, and to be fair, they are indeed not as sophisticated as MNC like Allianz, Prudential or AIA. Hence people tends to discount the EV multiple for China insurers. NB multiplier, should correlate with future sales. Typically people will assume NBV margin remains unchanged.
I found misconducts and management problems by his staff Desmond Choong who work deviated from Allianz rules. Can anyone advice how I can contact the CEO Mr. Zakri for stopping such risks to Shareholders, Allianz Malaysia and Malaysians?
I found misconducts and management problems by his staff Desmond Choong who work deviated from Allianz rules. Can anyone advice how I can contact the CEO Mr. Zakri for stopping such risks to Shareholders, Allianz Malaysia and Malaysians?
You ppl gonna know, her bank account only has RM15,000 and she trusted me to invest ALL in Tunepro....As i told her best and ideal price is RM0.370 but RM0.400 is still safe
Aim Lower Price, if possible aim to buy only below Intrinsic Value (IV)
and if possible, try to buy at the lowest point which is also known as the Price for Margin of Safety (PMOS) , i.e. less 25% of the IV, this will serve as a buffer to cushion for market fluctuation
Benjamin Graham's method is always the best way
It is proven that I used this method in Tunepro, Thong Guan, MBSB and BAT.
Now Allianz.
Value Investment Based on Fundamental Analysis is the way I have adopted since beginning of my investment journey
To be honest, I have not made any losses at all this year when I start to master the Great Grand Sifu Technic.
I need to admit I could not be imitating 100% the method adopted by Benjamin Graham, Warren Buffet or Charlie Munger.
But, I adjust and fine tune my investment way to be closer to their ways. I find that my risk has been reduced significantly and higher ROI in shorter time is the best evidence for using their ways.
There is an inspirational quote from Charlie Munger: The big money is not in the buying and the selling, but in the waiting. ... While waiting for others to fear, buying well-chosen stocks will bring “big money” to us easier.
The engine has been started, today broke RM13.00 point.
Aim for RM16 by end of year 2021 and hope for Special Dividend.
MCO during 2021, less claim and higher profit. Plus repricing in year 2021 will be the catalyst to push up the price to RM16.
Re-opening of economic activities means less default of premium and continuity of payment for insurance premium with higher consciousness for the need of insurance after this pandemic should be a driver for higher revenue and profit in upcoming years.
Stay tuned for good and positive news.
Disclaimer: - Buy or Sell or Hold is your own decision and responsibility. The information above is only for sharing as it is my personal view or opinion; the above information shall not be construed or deemed as an advice for any investment or divestment decision.
基本面价值投资是王道。我把股票投资当成长久的事业,会学习 Charlie Munger 说的,大钱之所以能赚多是等来的
我看好Allianz 会在今年年尾接近RM16, 没有买的人真的要快了
my funds used for investment ALL IN only two counters. You can imagine the quantities. BAT and Allianz as these two are very undervalued and they are slightly safer and I treat them as Sanctuary when US market is unstable right now
我走重仓路线,基本面价值投资。
Aim for RM16 by end of year 2021 and hope for Special Dividend. MCO during 2021, less claim and higher profit. Plus repricing in year 2021 will be the catalyst to push up the price to RM16.
Re-opening of economic activities means less default of premium and continuity of payment for insurance premium with higher consciousness for the need of insurance after this pandemic should be a driver for higher revenue and profit in upcoming years.
Stay tuned for good and positive news.
还没有买的人动作快了咯. Allianz 就飞了。我有很大的信心明天会继续飞,继续起价。
Hoseh 了咯,我等Special Dividend.真的飞了,没有骗人的啊
我正面分析了,年底或接近分股息的时候,我看好破RM16
the price is surging now as per my expectation when the price plummeted to below RM13
I expect Special Dividend and expect price to break or near to RM16 soon
Auditor, there are about equal number of preferential share which eventually will be converted to ordinary share. Do you think the IV will be halved after that?
Yup, the existing share value will be affected to the extent of number of newly issued ordinary shares upon the conversion of preference shares.
When convertible preferred stock holders choose to convert their stocks to common stocks, the stocks they receive are newly issued. This increases the total number of common shares. Because the number of common shares increases while the value of the company remains the same, the value of existing shares goes down.
May I know, normally for fund managers like those in big company such as ALLIANZ, etc. how to survive in bond market as the interest % is fluctuating? I am sure they've some ways to protect themselves?
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
wsb_investor
305 posts
Posted by wsb_investor > 2021-09-23 18:24 | Report Abuse
https://www.theedgemarkets.com/article/south-africas-sanlam-planning-stake-sale-malaysian-insurer-%E2%80%94-sources